Patents by Inventor Ofer Yodfat

Ofer Yodfat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170157324
    Abstract: Devices and methods for powering a medical device for sustained delivery of fluids or continuous monitoring of body analyte are disclosed. The devices may comprise a pumping mechanism, a driving mechanism for activating the pumping mechanism to dispense fluid, and a power source coupled to the driving mechanism and having an energy storage cell for providing a pulsed power to the driving mechanism. The methods may be implemented by activating the driving mechanism using pulsed energy in the form of at least one pulse train pattern accumulated in and discharged from an energy storage component.
    Type: Application
    Filed: February 17, 2017
    Publication date: June 8, 2017
    Inventors: Ofer Yodfat, Avihoo P. Keret
  • Patent number: 9669157
    Abstract: Disclosed is a skin securable therapeutic fluid dispensing device that includes a reservoir adapted to retain therapeutic fluid, a pump driving mechanism, and at least one housing configured to accommodate the reservoir and the pump driving mechanism, with at least a portion of the at least one housing defining at least a portion of the reservoir. The device also includes a shield coupled to the at least one housing, the shield configured to protect, at least in part, the reservoir from application of external forces thereon.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: June 6, 2017
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Ofer Arnold, Yair Dan
  • Publication number: 20170151387
    Abstract: Disclosed are methods, systems, devices and articles, including a method for adaptive wireless communication transmissions between units of an ambulatory portable medical device. The method includes obtaining data relating to wireless transmissions between the units of the medical device, and setting one or more attributes of wireless transmission of one or more messages between the units of the medical device based, at least in part, on the obtained data.
    Type: Application
    Filed: February 14, 2017
    Publication date: June 1, 2017
    Inventors: Ofer Yodfat, Avihoo P. Keret, Zohar Man, Tsabar Mor
  • Patent number: 9662440
    Abstract: Embodiments of the present invention are directed to devices, systems and methods for delivering therapeutic fluid (e.g., insulin) into the body, including a skin adherable cradle, for retaining a therapeutic fluid dispenser for delivering a therapeutic fluid to a user.
    Type: Grant
    Filed: December 20, 2007
    Date of Patent: May 30, 2017
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Gavriel J. Iddan, Avraham Neta
  • Patent number: 9597451
    Abstract: Embodiments of the present disclosure are directed to systems, devices/apparatuses and methods for assessing a residual insulin value for a user/patient. Such embodiments may be implemented by selecting a first value corresponding to a duration of insulin action; selecting a second value corresponding to a lock out time duration, selecting a first time period beginning at a time point T0 minus the first value and ending at the time point T0 minus the second value, selecting one or more boluses delivered during the first time period; for each of the one or more boluses selecting a corresponding residual insulin value estimated at the time point T0, computing the cumulative residual insulin value by summation of the corresponding residual insulin values.
    Type: Grant
    Filed: February 11, 2010
    Date of Patent: March 21, 2017
    Assignee: Roche Diagnostic Operations, Inc.
    Inventors: Ofer Yodfat, Gali Shapira, Iddo M. Gescheit
  • Patent number: 9592110
    Abstract: Some embodiments of the present disclosure are directed generally to systems and methods for delivering an implant to a body vessel of a patient. Such disclosed implants may be a monofilament implant, and disclosed systems for implanting the implant may be automatic. Some embodiments may enable retraction of said implant back into the delivery system following partial exteriorization of the implant from the delivery system. Some embodiments may be configured for retraction of said implant from the patient's body following complete exteriorization of the implant from the delivery system. Some of the embodiments are directed at delivering a monofilament implant for preventing embolic stroke. Other embodiments are directed at preventing pulmonary embolism, occluding a body vessel such as the left atrial appendage, occluding a body passageway such as a patent foramen ovalae, stenting a body vessel, or releasing a local therapeutic agent such as a drug or ionizing radiation.
    Type: Grant
    Filed: December 8, 2014
    Date of Patent: March 14, 2017
    Assignee: Javelin Medical, Ltd.
    Inventors: Yair Dan, Avraham Neta, Guy Shinar, Ofer Yodfat
  • Patent number: 9572924
    Abstract: Devices and methods for powering a medical device for sustained delivery of fluids or continuous monitoring of body analyte. The devices may comprise a pumping mechanism, a driving mechanism for activating the pumping mechanism to dispense fluid, and a power source coupled to the driving mechanism and having an energy storage cell for providing a pulsed power to the driving mechanism. The methods may be implemented by activating the driving mechanism using pulsed energy in the form of at least one pulse train pattern accumulated in and discharged from an energy storage component.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: February 21, 2017
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Avihoo P. Keret
  • Patent number: 9566383
    Abstract: Disclosed are methods, systems, devices and articles, including method for adaptive wireless communication transmissions between units of an ambulatory portable medical device. The method includes obtaining data relating to wireless transmissions between the units of the medical device, and setting one or more attributes of wireless transmission of one or more messages between the units of the medical device based, at least in part, on the obtained data.
    Type: Grant
    Filed: October 18, 2009
    Date of Patent: February 14, 2017
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Avihoo P. Keret, Zohar Man, Tsabar Mor
  • Patent number: 9486574
    Abstract: Disclosed is a portable therapeutic fluid dispensing device. The fluid dispensing device includes a reusable part (100) comprising a reusable part housing including at least a controller and a first portion (186) of a driving mechanism, and a disposable part (200) comprising a disposable part housing including at least a reservoir (220) to retain therapeutic fluid, an outlet port to which the therapeutic fluid is dispensed, a fluid conduit providing fluid communication between the reservoir and the outlet port, and a second portion (112) of the driving mechanism. At least a portion of the disposable part housing defines at least a portion of the reservoir. Also, the second portion of the driving mechanism is mechanically couplable to the first portion of the driving mechanism upon connection of the disposable part to the reusable part.
    Type: Grant
    Filed: October 25, 2013
    Date of Patent: November 8, 2016
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Yair Dan, Ofer Arnold, Avraham Neta, Yossi Shalev
  • Publication number: 20160303312
    Abstract: Disclosed is an ambulatory therapeutic fluid delivery device. The device includes at least one housing connectable to a cannula, the at least one housing retaining a reservoir to hold the therapeutic fluid. The device also includes a mechanically powered pumping mechanism to cause delivery of at least some of the fluid from the reservoir, and a power-transfer mechanism to transfer manually-delivered power provided by a user to mechanically actuate the pumping mechanism.
    Type: Application
    Filed: June 30, 2016
    Publication date: October 20, 2016
    Inventors: Ofer Yodfat, Gabriel J. Iddan, Illai Gescheit
  • Patent number: 9457145
    Abstract: Systems, devices and methods are presented in the subject disclosure for recommending an insulin dose adapted for use with an insulin delivery device. In some embodiments, the method may include receiving blood glucose (BG) data, determining one or more insulin sensitivity (IS) values associated with the BG data, and determining an insulin dose based on the determined one or more IS values. A system for carrying out such a method is also presented.
    Type: Grant
    Filed: January 20, 2011
    Date of Patent: October 4, 2016
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Gali Shapira, Iddo M. Gescheit
  • Patent number: 9446185
    Abstract: Devices and methods for delivering therapeutic fluid to a patient's body are described. The devices may comprise a dispensing unit having a reservoir, a driving mechanism having a movable member for delivering therapeutic fluid to a patient's body, at least one sensor for sensing a relative position of the movable member and generating a signal, and a processor for controlling the driving mechanism to deliver an amount of therapeutic fluid that compensates for a change in the flow of the therapeutic fluid occurring during fluid delivery. The methods may be implemented by operating the driving mechanism, receiving a signal based on the position of the movable member, determining an amount of therapeutic fluid to deliver, and controlling the driving mechanism to deliver an amount of fluid that compensates for a change in flow occurring during fluid delivery.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: September 20, 2016
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Avihoo P. Keret
  • Patent number: 9408967
    Abstract: Disclosed is an ambulatory therapeutic fluid delivery device. The device includes at least one housing connectable to a cannula, the at least one housing retaining a reservoir to hold the therapeutic fluid. The device also includes a mechanically powered pumping mechanism to cause delivery of at least some of the fluid from the reservoir, and a power-transfer mechanism to transfer manually-delivered power provided by a user to mechanically actuate the pumping mechanism.
    Type: Grant
    Filed: June 17, 2013
    Date of Patent: August 9, 2016
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Gabriel J. Iddan, Illai Gescheit
  • Patent number: 9387033
    Abstract: Products and methods directed to the improved infusion of fluids are disclosed. Such products and methods can be used to more efficiently and efficaciously administer therapeutic pharmaceuticals to a subject in need of treatment. In many instances, the systems comprise a therapeutic fluid delivery system and a mechanism for enhancing the absorption of the therapeutic fluid. The enhancement of the absorption of the therapeutic fluid is generally performed locally i.e., at or near the site of administration of the therapeutic fluid. The system and methods can be used to deliver any number of therapeutic fluids including but not limited to insulin.
    Type: Grant
    Filed: August 27, 2009
    Date of Patent: July 12, 2016
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Gali Shapira, Illai Gescheit
  • Publication number: 20160151142
    Abstract: Embodiments of the present disclosure are directed to systems, methods and devices for providing embolic protection in a patient. In some embodiments, the device is configured for implantation in a body vessel including fluid flow. The device may assume, or be constrained to assume, an undeployed state and a deployed state. In the undeployed state, the device or a portion thereof has a substantially linear shape configured to reside in the lumen of a thin needle having a diameter of less than about 0.5 mm (for example), in the deployed state, the device has a primary axis. When the device is implanted the primary axis is approximately perpendicular to the fluid flow. In some embodiments, the device comprises a thin filament body. In the deployed state the filament takes a helical shape. Emboli that are larger than the distance between consecutive turns or windings of the helix are thus filtered by the device and are prevented from causing deleterious conditions such as stroke or pulmonary embolism.
    Type: Application
    Filed: November 20, 2015
    Publication date: June 2, 2016
    Inventors: Guy Shinar, Ofer Yodfat
  • Publication number: 20160106918
    Abstract: A method and a system for determining insulin sensitivity (IS) is described. In one aspect the method and the system can be implemented by receiving a first parameter corresponding to an insulin dose in a subcutaneous tissue; applying a first kinetic model to obtain a plasma insulin concentration based on the first parameter; receiving a second parameter corresponding to a plasma glucose concentration; determining the insulin sensitivity (IS) based on the plasma insulin concentration and the second parameter.
    Type: Application
    Filed: December 21, 2015
    Publication date: April 21, 2016
    Inventors: Ofer Yodfat, Gali Shapira, Iddo Gescheit
  • Publication number: 20160106914
    Abstract: Disclosed is a fluid dispensing device that includes at least one reservoir to hold the therapeutic fluid, at least one other unit requiring communication with ambient air, at least partly, to operate, and at least one housing defining an interior to retain the at least one reservoir and the at least one other unit. The at least one housing has at least one vent port formed on one or more of its walls. The at least one vent port is adapted to direct or communicate air to maintain pressure equilibrium between the air pressure in the interior of the at least one housing and the ambient air pressure outside the at least one housing, and provide communication with the ambient air to the at least one other unit requiring air to enable operation of the at least one other unit.
    Type: Application
    Filed: December 22, 2015
    Publication date: April 21, 2016
    Inventors: Ofer Yodfat, Avraham Neta
  • Publication number: 20160106917
    Abstract: The present disclosure presents systems, devices and methods for administration of a therapeutic fluid to the body of a patient at a transient basal delivery profile, and enabling modification of the transient profile. Some embodiments include a user interface enabling input of one or more transient basal related parameters, and a processor having a basal programming application operating thereon. The basal programming application configured for determining a transient basal profile based on at least one or more transient basal related parameters. The transient basal profile comprises a plurality of phases and wherein each of the plurality of phases is characterized by a duration and at least one basal rate. In some embodiments, at least one of the plurality of phases includes either a basal overshot or a basal undershot. Some embodiments may also include a pump for dispensing the therapeutic fluid from a reservoir to the body of the patient.
    Type: Application
    Filed: December 28, 2015
    Publication date: April 21, 2016
    Inventors: Ofer Yodfat, Gali Shapira
  • Publication number: 20160074577
    Abstract: A portable therapeutic fluid delivery device with a flow detector comprising a heating element and two temperature sensors is presented. Upon activation of the heating element, a flow condition of the fluid inside the delivery tube is determined based on a signal provided by the temperature sensors. A temperature gradient within the therapeutic fluid is detected. The determined flow condition can be one of: air bubbles within the delivery tube, occlusion within the delivery tube, or leakage within the delivery tube. The device can have two parts, for example, a reusable part and a disposable part. Upon pairing of these parts, the heating element and the temperature sensors touch the delivery tube.
    Type: Application
    Filed: November 24, 2015
    Publication date: March 17, 2016
    Inventors: Avraham Neta, Konstantin Tsypko, Nikolay Tsypko, Ofer Yodfat
  • Patent number: 9254359
    Abstract: Disclosed is a fluid dispensing device that includes at least one reservoir to hold the therapeutic fluid, at least one other unit requiring communication with ambient air, at least partly, to operate, and at least one housing defining an interior to retain the at least one reservoir and the at least one other unit. The at least one housing has at least one vent port formed on one or more of its walls. The at least one vent port is adapted to direct or communicate air to maintain pressure equilibrium between the air pressure in the interior of the at least one housing and the ambient air pressure outside the at least one housing, and provide communication with the ambient air to the at least one other unit requiring air to enable operation of the at least one other unit.
    Type: Grant
    Filed: July 22, 2013
    Date of Patent: February 9, 2016
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Ofer Yodfat, Avraham Neta